New Milestone as Sweden Enshrines Policy That Can Turn World Smoke-Free
Sweden has enshrined tobacco harm reduction in public health policy after becoming the first nation to prove it’s the most effective path to a smoke-free future.
Thanks to Sweden’s stance on safer nicotine alternatives, just 4.5% of Swedish-born adults now smoke - below the 5% smoke-free threshold.
This success has led Parliament to formally adopt harm reduction, reinforcing Sweden’s role as a global leader in public health innovation.
Dr. Delon Human, leader of Smoke Free Sweden, says:
“Swedes have participated in a long-running harm reduction experiment, providing undeniable proof that replacing smoking with smokeless nicotine dramatically reduces smoking-related disease, disability and premature deaths - a net gain for public health, while reducing expenditure.
“With harm reduction now policy in Sweden, every public health decision will reflect this approach. Other countries should adopt Sweden’s model without further delay.”
Rather than reducing tobacco use, Sweden now prioritises reducing harm by encouraging smokers to switch to safer alternatives like snus, nicotine pouches and vapes.
Adopted by Parliament in December 2024, the policy states:
“…tobacco policy must consider the varying harmful effects of different products. Cigarettes pose a greater health hazard than smokeless nicotine… This must be reflected in taxation and policy goals.”
Sweden has already applied risk-based taxation by lowering excise tax on snus while increasing it on cigarettes.
“Sweden’s formal adoption of harm reduction is a global milestone,” says Dr. Human. “With smoking rates at 5.3%, Sweden is set to become the first smoke-free nation. Policymakers serious about reducing smoking-related deaths must follow suit.”
Sweden’s success is remarkable. Among Swedish citizens born elsewhere in Europe, the smoking rate is 7.8% - less than a third of the EU average. The public health benefits mean Sweden has 41% fewer cancer cases than the European average and 44% lower tobacco-related mortality.
Other nations applying Sweden’s model are seeing similar results. New Zealand has nearly halved smoking rates (12.2% in 2018 to 6.9% in 2024) by promoting vaping, while Japan saw a 43% drop in cigarette sales from 2015 to 2020 as smokers switched to heated tobacco products. In the UK, nearly three million quit smoking using vapes in five years.
Dr. Human concludes: “In every tobacco control discussion, regulators should ask, ‘How have Swedes made smoking history, while saving lives?’”
View source version on businesswire.com: https://www.businesswire.com/news/home/20250325703036/en/
Contacts
Jessica Perkins
info@smokefreesweden.org
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VeriSilicon Introduces AcuityPercept: an AI-Powered Automatic ISP Tuning System31.3.2025 02:00:00 CEST | Press Release
VeriSilicon (688521.SH) today announced AcuityPercept, its AI-based automatic Image Signal Processing (ISP) tuning system, designed to intelligently optimize image processing parameters for enhanced object recognition. AcuityPercept improves the accuracy and efficiency of AI perception systems by dynamically optimizing ISP parameters through automated tuning processes. It is widely applicable to AI-powered vision applications across various industries, including autonomous driving, robotic vision, and AIoT. VeriSilicon’s AcuityPercept leverages a global directive and local refinement algorithm, utilizing metadata and loss feedback from AI task models to automatically achieve optimal ISP tuning. By continuously refining ISP settings, it effectively enhances object detection accuracy and delivers optimal ISP-processed images for neural network processing. AcuityPercept delivers a comprehensive optimization solution with VeriSilicon’s ISP IP, enabling automated closed-loop optimization. “
SLB Announces First-Quarter 2025 Results Conference Call28.3.2025 18:01:00 CET | Press Release
SLB (NYSE: SLB) will hold a conference call on April 25, 2025 to discuss the results for the first quarter ending March 31, 2025. The conference call is scheduled to begin at 9:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 114893. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/581727555 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 2, 2025, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929) 458-6
Presidio Investors Welcomes Wynee Sade as Newest Operating Partner28.3.2025 16:32:00 CET | Press Release
Presidio Investors is pleased to announce the addition of Wynee Sade as its newest Operating Partner. With over 25 years of global sales and marketing experience, Wynee has held senior leadership roles across a range of industries, including Chief Marketing Officer at Forager Project and leadership positions at Qooco, AppSymth, and Shopkick. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327178560/en/ Wynee Sade, Presidio Investors Operating Partner Wynee’s expertise in driving growth, building brands, and leading high-performing teams has shaped organizations from early-stage startups to established Fortune 500 companies. She has a proven track record of scaling businesses and delivering impactful solutions. Wynee is also the founder of Yu Ming Charter School, California’s first public K-8 Mandarin immersion school, which has earned numerous accolades, including National Blue Ribbon recognition. Wynee holds an MBA from H
Join the 2025 Global Challenger Innovation Contest: Driving Inclusion Through Innovation28.3.2025 16:12:00 CET | Press Release
The 10x1000 Tech for Inclusion community and next-generation corporate venture partner xcube.co launched the Global Challenger Innovation Contest 2025 at the JUMPSTARTER 2025 event in Hong Kong SAR, China, building on the success of the 2024 competition. Now in its second year, the contest continues to empower visionaries to create tech-driven solutions that promote inclusion and drive social impact. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250328955793/en/ 10x1000 Tech for Inclusion and xcube.co jointly launched the Global Challenger Innovation Contest in Hong Kong SAR, China, at the JUMPSTARTER 2025 event. The Global Challenger Innovation Contest was inaugurated in 2024 as a flagship project of 10x1000 Tech for Inclusion, a global initiative supported by the International Finance Corporation (IFC) and Ant International, to empower emerging tech leaders to create innovative solutions for financial inclusion and social
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category28.3.2025 14:22:00 CET | Press Release
Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327305519/en/ Altasciences receives a 2025 CDMO Leadership Award in the Small Molecule Dosage Form (North America) category. Altasciences’ CDMO site supports drug development with formulation, manufacturing, and analytical testing—from discovery to commercialization. Their FDA-inspected facility features Grade C cleanrooms, R&D and analytical labs, ICH stability chambers, and a cGMP warehouse. "This recognition reflects our CDMO team’s unwavering dedication and expertise, as well as our unrelenting commitment to advancing drug development in collaboration with leading pharmaceutical and biotech innovators,” says Marie-Hélène Raigneau, Co-Chief Operating Officer at Altasciences. “We are gratefu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom